View DividendPrestige Biologics 관리관리 기준 확인 0/4현재 CEO에 대한 정보가 충분하지 않습니다.주요 정보 최고 경영자n/a총 보상CEO 급여 비율n/aCEO 임기no dataCEO 소유권n/a경영진 평균 재임 기간데이터 없음이사회 평균 재임 기간데이터 없음최근 관리 업데이트Prestige Biologics Co., Ltd., Annual General Meeting, Sep 27, 2024Sep 13모든 업데이트 표시Recent updatesNew major risk - Financial position Nov 22New minor risk - Shareholder dilution Oct 25Prestige Biologics Co., Ltd. announced that it has received KRW 89.9263492 billion in fundingSep 25Prestige Biologics Co., Ltd., Annual General Meeting, Sep 27, 2024Sep 13New major risk - Financial data availability Aug 29New minor risk - Share price stability Aug 19New minor risk - Financial data availability Mar 16New major risk - Financial position Sep 19Prestige Biologics Co., Ltd. announced that it has received KRW 6.893915 billion in funding from Prestige BioPharma LimitedSep 07CEOPrestige Biologics 에는 CEO가 없거나 그에 대한 데이터가 없습니다.View Ownership
Prestige Biologics Co., Ltd. announced that it has received KRW 6.893915 billion in funding from Prestige BioPharma LimitedSep 07